Ballentine Partners, LLC ABCL ABCELLERA BIOLOGICS INC

Ownership history in Ballentine Partners, LLC  ·  7 quarters on record

AI Ownership Summary

Ballentine Partners, LLC reported ABCELLERA BIOLOGICS INC (ABCL) in 7 quarterly 13F filings from 2024 Q3 through 2026 Q2. The latest visible filing shows ABCL at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ABCL ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Ballentine Partners, LLC's position in ABCELLERA BIOLOGICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

ABCL was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Ballentine Partners, LLC held ABCL — position size vs. price
% of Fund (quarterly)    ABCL price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 18,656 -649 -3.4% 0.00% $146K 2026-07-17 $6.47
2026 Q1 ADDED 19,305 +702 +3.8% 0.00% $67K 2026-05-14 $4.40
2025 Q4 REDUCED 25.6% +2.0% 18,603 -6,408 -25.6% 0.00% $64K 2026-02-03 $3.52
2025 Q3 ADDED 25,011 +1,322 +5.6% 0.00% $126K 2025-11-03 $5.37
2025 Q2 ADDED 23,689 +3,747 +18.8% 0.00% $81K 2025-07-15 $3.94
2024 Q4 REDUCED 19,942 -790 -3.8% 0.00% $58K 2025-01-16 $2.94
2024 Q3 INITIATED 20,732 0.00% $54K 2024-10-23 $2.78

FAQ About Ballentine Partners, LLC and ABCL

These are the practical questions this page is built to answer before you even open the full history table.

How long has Ballentine Partners, LLC reported owning ABCL?

Ballentine Partners, LLC reported ABCL across 7 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported ABCL position in Ballentine Partners, LLC's portfolio?

The largest reported portfolio weight for ABCL was 0.00% in 2026 Q2.

What is the latest reported ABCL position on this page?

The most recent filing on this page is 2026 Q2, when Ballentine Partners, LLC reported 18,656 shares, equal to 0.00% of portfolio, with an estimated market value of $146K.

What does the chart on this ABCL ownership page compare?

The chart compares Ballentine Partners, LLC's quarterly ABCL portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Ballentine Partners, LLC time their ABCL position?

Based on 13F filing dates vs. subsequent ABCL price moves, Ballentine Partners, LLC correctly timed 3 out of 6 reported position changes (50%). The annualised alpha on ABCL relative to SPY over the holding period was +39.2%.

← Back to Ballentine Partners, LLC Holdings